SCRI Tennessee Oncology- Gallatin

Gallatin, Tennessee 37066

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Gallatin, TN
Click here to add this to my saved trials